Affordable, Tailored Physical Therapy for Financially Vulnerable People With Trauma-related Injuries (AFTER-TRAUMA) (AFTER-TRAUMA)
Affordable, Tailored Physical Therapy for Financially Vulnerable People With Trauma-related Injuries (AFTER-TRAUMA): a Prospective Cohort Study
SUMMARY
Rationale: In the Netherlands, trauma-related injuries affect more than 700,000 people annually, and many require rehabilitation. Regardless of trauma-related injuries, over 500,000 individuals live in financial vulnerability, often characterized as having low socioeconomic status (SES). Patients with low SES have an increased risk of sustaining trauma and generally experience poorer recovery outcomes. Access to physical therapy care is limited for this population, despite the substantial impact of trauma on quality of life and daily functioning. Little is known about their long-term rehabilitation outcomes. This study aims to improve understanding of recovery patterns in patients with trauma-related injuries and explores whether outcomes differ between SES-groups.
Objective: The primary objective is to assess quality of life 1 week prior to the injury, and at 1 week, 6 weeks, 12 weeks, 6 months, and 1 year after trauma-related injury. Secondary objectives include evaluating social, physical and mental functioning, fatigue, pain, and return-to-work. Outcomes will be compared across socioeconomic groups to explore how financial vulnerability is associated with recovery.
Study design: Prospective, longitudinal cohort study. Study population: In total 185 patients (≥18 years) with trauma-related injuries (ISS ≥9) admitted to the Radboud University Medical Center will be included between April 2026 and October 2027.
Main study parameters/endpoints: The primary outcome is quality of life, measured using validated PROMIS® Global02 at all follow-up timepoints. Secondary outcomes include perceived health, social, physical, and mental functioning, fatigue, and pain, assessed using validated PROMIS® questionnaires at the same follow up moments. SES indicators (postal code, education level, type of employment), health insurance coverage, and work status will also be collected.
Nature and extent of the burden and risks associated with participation, benefit, and group relatedness: Participation involves minimal burden and no medical risks. Patients are asked to complete digital of paper questionnaires at predefined intervals with a burden of approximately 10 minutes per follow-up interval. No additional procedures or treatments are required. The participant will receive a compensation of €5 for each completed questionnaire. The study is expected to generate valuable insights that can improve quality, accessibility, and tailoring of physical therapy care for future trauma patients, particularly those in a financially vulnerable situation.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Estimé)
Contacts et emplacements
Coordonnées de l'étude
- Nom: Indy Smits, MSc
- Numéro de téléphone: +243614892
- E-mail: indy.smits@radboudumc.nl
Sauvegarde des contacts de l'étude
- Nom: Niek Koenders, PhD
- Numéro de téléphone: +243614892
Lieux d'étude
-
-
Gelderland
-
Nijmegen, Gelderland, Pays-Bas, 6525
- Recrutement
- Radboud University Medical Center
-
Contact:
- Indy Smits, MSc
- Numéro de téléphone: +243614892
- E-mail: indy.smits@radboudumc.nl
-
Chercheur principal:
- Niek Koenders, PhD
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
Méthode d'échantillonnage
Population étudiée
La description
Inclusion Criteria:
- Adults ≥ 18 years
- Trauma-related injury and an Injury Severity Score (ISS) ≥ 9 points
- Admitted ≥ 24 hours to the Radboudumc
Exclusion Criteria:
- Delirium, dementia, or depression
- Unable to participate in the informed consent procedure
- Life expectancy < 3 months
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Cohortes et interventions
Groupe / Cohorte |
Intervention / Traitement |
|---|---|
|
Multitrauma
Trauma patients with an ISS >8
|
PROMIS Questionnaires
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Health-related quality of life measured by PROMIS® Global-02
Délai: 1 week before injury (retrospectively assessed at enrolment), 1 week, 6 weeks, 12 weeks, 6 months, and 12 months after injury.
|
Health-related quality of life is assessed using PROMIS® Global02.
Participants rate their overall quality of life on a 5-point scale ranging from 1 (poor) to 5 (excellent).
Higher scores indicate better health-related quality of life.
|
1 week before injury (retrospectively assessed at enrolment), 1 week, 6 weeks, 12 weeks, 6 months, and 12 months after injury.
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Perceived health measured by PROMIS® Global01
Délai: Baseline (1 week prior to injury, assessed retrospectively at enrolment), 1 week, 6 weeks, 12 weeks, 6 months, and 12 months after injury.
|
Perceived health is assessed using PROMIS® Global01.
Participants rate their overall health on a 5-point scale ranging from 1 (poor) to 5 (excellent).
Higher scores indicate better perceived health.
|
Baseline (1 week prior to injury, assessed retrospectively at enrolment), 1 week, 6 weeks, 12 weeks, 6 months, and 12 months after injury.
|
|
Social functioning measured by PROMIS® Ability to Participate in Social Roles and Activities Short Form 4a
Délai: Baseline (1 week prior to injury, assessed retrospectively at enrolment), 1 week, 6 weeks, 12 weeks, 6 months, and 12 months after injury.
|
Social functioning is assessed using the PROMIS® Ability to Participate in Social Roles and Activities Short Form 4a.
The questionnaire contains 4 items scored on 5-point response scales.
Total scores range from 4 to 20.
Higher scores indicate better social functioning and participation.
|
Baseline (1 week prior to injury, assessed retrospectively at enrolment), 1 week, 6 weeks, 12 weeks, 6 months, and 12 months after injury.
|
|
Physical functioning measured by PROMIS® Physical Function Short Form 8b
Délai: Baseline (1 week prior to injury, assessed retrospectively at enrolment), 1 week, 6 weeks, 12 weeks, 6 months, and 12 months after injury.
|
Physical functioning is assessed using the PROMIS® Physical Function Short Form 8b.
The questionnaire contains 8 items scored on 5-point response scales.
Total scores range from 8 to 40.
Higher scores indicate better physical functioning.
|
Baseline (1 week prior to injury, assessed retrospectively at enrolment), 1 week, 6 weeks, 12 weeks, 6 months, and 12 months after injury.
|
|
Anxiety measured by PROMIS® Anxiety Short Form 4a
Délai: Baseline (1 week prior to injury, assessed retrospectively at enrolment), 1 week, 6 weeks, 12 weeks, 6 months, and 12 months after injury.
|
Anxiety is assessed using the PROMIS® Anxiety Short Form 4a.
The questionnaire contains 4 items scored from 1 to 5. Total scores range from 4 to 20.
Higher scores indicate greater anxiety symptoms.
|
Baseline (1 week prior to injury, assessed retrospectively at enrolment), 1 week, 6 weeks, 12 weeks, 6 months, and 12 months after injury.
|
|
Depressive symptoms measured by PROMIS® Depression Short Form 4a
Délai: Baseline (1 week prior to injury, assessed retrospectively at enrolment), 1 week, 6 weeks, 12 weeks, 6 months, and 12 months after injury.
|
Depressive symptoms are assessed using the PROMIS® Depression Short Form 4a.
The questionnaire contains 4 items scored from 1 to 5. Total scores range from 4 to 20.
Higher scores indicate greater depressive symptoms
|
Baseline (1 week prior to injury, assessed retrospectively at enrolment), 1 week, 6 weeks, 12 weeks, 6 months, and 12 months after injury.
|
|
Fatigue measured by PROMIS® Fatigue Short Form 4a
Délai: Baseline (1 week prior to injury, assessed retrospectively at enrolment), 1 week, 6 weeks, 12 weeks, 6 months, and 12 months after injury.
|
Fatigue is assessed using the PROMIS® Fatigue Short Form 4a.
The questionnaire contains 4 items scored from 1 to 5. Total scores range from 4 to 20.
Higher scores indicate greater fatigue.
|
Baseline (1 week prior to injury, assessed retrospectively at enrolment), 1 week, 6 weeks, 12 weeks, 6 months, and 12 months after injury.
|
|
Pain intensity measured by PROMIS® Numeric Rating Scale v1.0 Pain Intensity 1a
Délai: Baseline (1 week prior to injury, assessed retrospectively at enrolment), 1 week, 6 weeks, 12 weeks, 6 months, and 12 months after injury.
|
Pain intensity is assessed using the PROMIS® Numeric Rating Scale v1.0 Pain Intensity 1a.
Scores range from 0 (no pain) to 10 (worst imaginable pain).
Higher scores indicate greater pain intensity.
|
Baseline (1 week prior to injury, assessed retrospectively at enrolment), 1 week, 6 weeks, 12 weeks, 6 months, and 12 months after injury.
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chaise d'étude: Niek Koenders, PhD, Radboud University Medical Center
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- NL2026-18844
- WCF CALL 2024-2025 (Autre subvention/numéro de financement: Wetenschappelijk College Fysiotherapie (KNGF))
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .